Medicine & Life Sciences
oxyhyponitrite
100%
Cardiac Myocytes
96%
nitroxyl
84%
Unsaturated Dietary Fats
78%
Guanosine Monophosphate
77%
Fluorescence Resonance Energy Transfer
69%
Soluble Guanylyl Cyclase
66%
Calcium-Calmodulin-Dependent Protein Kinase Type 2
66%
Calcium-Calmodulin-Dependent Protein Kinases
65%
Fish Oils
63%
Left Ventricular Hypertrophy
55%
Superoxides
52%
Hypertrophy
47%
Nitric Oxide
42%
Cardiomegaly
36%
Diet
35%
Angiotensin II
29%
Transgenic Mice
24%
Heart
20%
NADPH Oxidases
19%
Reperfusion
17%
Unsaturated Fatty Acids
17%
Muscle Cells
15%
Cyclic GMP-Dependent Protein Kinase Type I
15%
vasodilator-stimulated phosphoprotein
13%
Guanylate Cyclase
12%
Natriuretic Peptides
12%
Investigational Therapies
12%
Phosphodiesterase Inhibitors
12%
Nitric Oxide Donors
12%
Ventricular Remodeling
12%
Therapeutics
11%
Drug Therapy
11%
Biosensing Techniques
10%
Myosin Heavy Chains
10%
Cardiovascular System
10%
Standard of Care
10%
Brain Natriuretic Peptide
9%
Nitrites
9%
Phosphorylation
8%
p38 Mitogen-Activated Protein Kinases
8%
Omega-3 Fatty Acids
8%
Vasodilation
8%
Oxidation-Reduction
8%
Disease Progression
8%
Pressure
7%
Ligands
7%
Cardiac Arrhythmias
6%
Blood Pressure
6%
Heart Failure
6%
Agriculture & Biology
guanylate cyclase
64%
cardiomyocytes
63%
hypertrophy
55%
superoxide anion
48%
salts
29%
angiotensin II
29%
NAD(P)H oxidase (H2O2-forming)
20%
cGMP-dependent protein kinase
12%
natriuretic peptides
12%
heart failure
12%
myosin heavy chains
10%
vasodilator agents
10%
phosphoproteins
10%
vasodilation
10%
cardiovascular diseases
9%
mitogen-activated protein kinase
9%
nitrites
8%
drug therapy
8%
risk factors
8%
phosphorylation
7%
neonates
7%
therapeutics
6%
death
6%
protein synthesis
6%
sodium
6%